BC
binbin cheng
Hubei Provincial Key Laboratory of Occurrence and Intervention of Kidney Diseases, Hubei Provincial Engineering Research Center of Immunotherapy Drugs for Renal Tumors, Hubei Polytechnic University, School of Medicine
China
Authors
- BL
bruno laugel
Institut Servier d’Innovation Thérapeutique, Paris-Saclay R&D Center, Rue Francis Perrin
France
- CL
chaxian liu
Department of Neurosurgery, Huashan Hospital, Fudan University
China
- CH
chih-ping han
Department of Biotechnology Medicine, MacKay Memorial Hospital
Taiwan
- CM
chong mao
Department of Dermatology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China
China
- CS
chunyan sun
Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
China
- CZ
conghui zhang
Department of Ophthalmology, Shanghai East Hospital, School of Medicine, Tongji University
China
- DA
daniel andersen
Servier Symphogen A/S
Denmark
- EL
erwei li
Department of Blood Transfusion, Fuwai Central China Cardiovascular Hospital, Henan Cardiovascular Disease Center (Central China Subcenter of National Center for Cardiovascular Diseases), Central China Fuwai Hospital of Zhengzhou University, Henan Provincial Cardiovascular Hospital
China
- FM
fabien melchiore
Institut Servier de Médecine Translationnelle, Paris-Saclay R&D Center, Rue Francis Perrin
France
- HJ
haiying jin
Department of Ophthalmology, Shanghai East Hospital, School of Medicine, Tongji University
China
- HZ
haiyu zhang
Department of Transfusion, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China
China
...
